Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation

References

• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998;9:717–720.
   PubMed Web of Science ®Google Scholar
• Fisher RI, LeBlanc M, Press OW, et al. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005;23:8447–8452.
   PubMed Web of Science ®Google Scholar
• Swenson WT, Wooldridge JE, Lynch CF, et al. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005;23:5019–5026.
   PubMed Web of Science ®Google Scholar
• Bastion Y, Sebban C, Berger F, et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 1997;15:1587–1594.
   PubMed Web of Science ®Google Scholar
• Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007;25:2426–2433.
   PubMed Web of Science ®Google Scholar
• Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol 2008;26:5165–5169.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185–1189.
   PubMed Web of Science ®Google Scholar
• Kridel R, Sehn LH, Gascoyne RD. Pathogenesis of follicular lymphoma. J Clin Investigat 2012;122:3424–3431.
   PubMed Web of Science ®Google Scholar
• McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79–88.
   PubMed Web of Science ®Google Scholar
• Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18–29.
   PubMed Web of Science ®Google Scholar
• Eide MB, Liestøl K, Lingjaerde OC, et al. Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. Blood 2010;116:1489–1497.
   PubMed Web of Science ®Google Scholar
• Jacob J, Kelsoe G, Rajewsky K, et al. Intraclonal generation of antibody mutants in germinal centres. Nature 1991;354:389–392.
   PubMed Web of Science ®Google Scholar
• Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751–758.
   PubMed Web of Science ®Google Scholar
• Dickerson SK, Market E, Besmer E, et al. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med 2003;197:1291–1296.
   PubMed Web of Science ®Google Scholar
• Pham P, Bransteitter R, Petruska J, et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003;424:103–107.
   PubMed Web of Science ®Google Scholar
• Liu M, Schatz DG. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol 2009;30:173–181.
   PubMed Web of Science ®Google Scholar
• Pettersen HS, Galashevskaya A, Doseth B, et al. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature. DNA Repair (Amst) 2014;25C:60–71.
   Google Scholar
• Liu M, Duke JL, Richter DJ, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008;451:841–845.
   PubMed Web of Science ®Google Scholar
• Greeve J, Philipsen A, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lym- phomas. Blood 2003;101:3574–3580.
   PubMed Web of Science ®Google Scholar
• Smit LA, Bende RJ, Aten J, et al. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003;63:3894–3898.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004;18:1775–1779.
   PubMed Web of Science ®Google Scholar
• Aarts WM, Bende RJ, Steenbergen EJ, et al. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 2000; 95:2922–2929.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Kosmas C, Papadaki T, et al. Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol 1997;96:132–146.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001;412:341–346.
   PubMed Web of Science ®Google Scholar
• Zhu D, Hawkins RE, Hamblin TJ, et al. Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol 1994;86:505–512.
   PubMed Web of Science ®Google Scholar
• Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998;91:4292–4299.
   PubMed Web of Science ®Google Scholar
• Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 1995;92:12520–12524.
   PubMed Web of Science ®Google Scholar
• Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000;95:651–659.
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994;83:1757–1759.
   PubMed Web of Science ®Google Scholar
• Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993;262: 747–750.
   PubMed Web of Science ®Google Scholar
• Seyfert VL, Allman D, He Y, et al. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 1996;12:2331–2342.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Migliazza A, Ye B, et al. Transcriptional deregulation of mutated BCL6 alleles by loss of negative autoregulation in diffuse large B cell lymphoma. Ann NY Acad Sci 2003;987:314–315.
   Web of Science ®Google Scholar
• Pasqualucci L, Migliazza A, Basso K, et al. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003;101:2914–2923.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 2000;96:635–639.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008;40: 108–112.
   PubMed Web of Science ®Google Scholar
• Bertinetti C, Zirlik K, Heining-Mikesch K, et al. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res 2006;66:4496–4502.
   PubMed Web of Science ®Google Scholar
• Navarrete MA, Heining-Mikesch K, Schuler F, et al. Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma. Blood 2011;117:1483–1491.
   PubMed Web of Science ®Google Scholar
• Bertinetti C, Simon F, Zirlik K, et al. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli. Eur J Haematol 2006;77:395–402.
   PubMed Web of Science ®Google Scholar
• Osterroth F, Alkan O, Mackensen A, et al. Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination. J Immunol Meth 1999;229: 141–153.
   PubMed Web of Science ®Google Scholar
• Giudicelli V, Brochet X, Lefranc MP. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc 2011;2011: 695–715.
   PubMedGoogle Scholar
• Volpe JM, Cowell LG, Kepler TB. SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics 2006;22:438–444.
   PubMed Web of Science ®Google Scholar
• Shahaf G, Barak M, Zuckerman NS, et al. Antigen-driven selection in germinal centers as reflected by the shape characteristics of immunoglobulin gene lineage trees: a large-scale simulation study. J Theor Biol 2008;255:210–222.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Levy R. Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity. Blood 2000;95:1400–1405.
   PubMed Web of Science ®Google Scholar
• Jardin F, Ruminy P, Parmentier F, et al. Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma. Leukemia 2005;19:1824–1830.
   PubMed Web of Science ®Google Scholar
• Hardianti MS, Tatsumi E, Syampurnawati M, et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 2004;18:826–831.
   PubMed Web of Science ®Google Scholar
• Martin A, Scharff MD. Somatic hypermutation of the AID transgene in B and non-B-cells. Proc Natl Acad Sci USA 2002;99: 12304–12308.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood 2004; 104:3318–3325.
   PubMed Web of Science ®Google Scholar
• Storck S, Aoufouchi S, Weill JC, et al. AID and partners: for better and (not) for worse. Curr Opin Immunol 2011;23:337–344.
   PubMed Web of Science ®Google Scholar
• Palacios F, Moreno P, Morande P, et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010;115:4488–4496.
   PubMed Web of Science ®Google Scholar
• Heintel D, Kroemer E, Kienle D, et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004;18:756–762.
   PubMed Web of Science ®Google Scholar
• Shikata H, Yakushijin Y, Matsushita N, et al. Role of activation-induced cytidine deaminase in the progression of follicular lymphoma. Cancer Sci 2012;103:415–421.
   PubMed Web of Science ®Google Scholar